The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis
Abstract
Methamphetamine (METH) is a drug of abuse that has long been known to damage monoaminergic systems in the mammalian brain. Recent reports have provided conclusive evidence that METH can cause neuropathological changes in the rodent brain via apoptotic mechanisms akin to those reported in various models of neuronal death. The purpose of this review is to provide an interim account for a role of oxygen‐based radicals and the participation of transcription factors and the involvement of cell death genes in METH‐induced neurodegeneration. We discuss data suggesting the participation of endoplasmic reticulum and mitochondria‐mediated activation of caspase‐dependent and ‐independent cascades in the manifestation of METH‐induced apoptosis. Studies that use more comprehensive approaches to gene expression profiling should allow us to draw more instructive molecular portraits of the complex plastic and degenerative effects of this drug.—Cadet, J. L., Jayanthi, S., Deng, X. Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17, 1775–1788 (2003)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methamphetamine (MA) is a psychostimulant that when used regularly is associated with harms such as injecting and sexual risk-taking behaviour, symptoms of mental ill health (eg, psychosis, aggression, depression and/or anxiety), psychomotor, social and cognitive impairment, criminal activity and sometimes death caused by overdose.1–7”
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Caspases: the executioners of apoptosis
Cohen, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,737
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Peroxynitrite oxidation of sulfhydryls.
Radí, R., Beckman, J. S., Bush, K., & Freeman, B. Α. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,492
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,125
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H. E., Stevens, J. L., & Ron, D. (1998) · Genes & Development · doi:10.1101/gad.12.7.982 · Cited by 2,039
Research works printed but not linked: 1
- Cadet J. L., 2003, Gluamate and Addiction, 201
Cited by
Sorted by citations
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
Self-citationPaulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.761 · Cited by 369
Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 319
Jayanthi, S., Deng, X., Noailles, P., Ladenheim, B., & Cadet, J. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0295com · Cited by 281
Self-citationNeurotoxicity of substituted amphetamines: Molecular and cellular mechanisms
Cadet, J. L., Krasnova, I. N., Jayanthi, S., & Lyles, J. (2007) · Neurotoxicity Research · doi:10.1007/bf03033567 · Cited by 271
Self-citationDrugs and alcohol: Treating and preventing abuse, addiction and their medical consequences
Volkow, N. D., & Li, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.021 · Cited by 247
Jayanthi, S., Deng, X., Ladenheim, B., McCoy, M. T., Cluster, A. S., Cai, N.-S., & Cadet, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404990102 · Cited by 223
Self-citationNeurotoxicity of methamphetamine: Main effects and mechanisms
Jayanthi, S., Daiwile, A. P., & Cadet, J. L. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113795 · Cited by 238
Self-citationMethamphetamine: Effects on the brain, gut and immune system
Prakash, M. D., Tangalakis, K., Antonipillai, J., Stojanovska, L., Nurgali, K., & Apostolopoulos, V. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.009 · Cited by 220
Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity
LaVoie, M. J., Card, J. P., & Hastings, T. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.010 · Cited by 204
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti, D. M., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 192
Vearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J., & Haggerty, D. A. (2012) · Disease-a-Month · doi:10.1016/j.disamonth.2011.09.004 · Cited by 191
Regulation of the dopamine transporter
Schmitt, K. C., & Reith, M. E. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05148.x · Cited by 186
Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
Yu, S., Zhu, L., Shen, Q., Bai, X., & Di, X. (2015) · Behavioural Neurology · doi:10.1155/2015/103969 · Cited by 176
Dietrich, J.-B., Mangeol, A., Revel, M.-O., Burgun, C., Aunis, D., & Zwiller, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.018 · Cited by 168
Dopaminergic neuron-specific oxidative stress caused by dopamine itself.
Miyazaki, I., & Asanuma, M. (2008) · PubMed · doi:10.18926/amo/30942 · Cited by 168
Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.015 · Cited by 159
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Nguyen, E. C., McCracken, K. A., Liu, Y., Pouw, B., & Matsumoto, R. R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.016 · Cited by 146
Wu, C.-W., Ping, Y., Yen, J., Chang, C., Wang, S., Yeh, C.-L., Chi, C., & Lee, H. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.011 · Cited by 143
Fukami, G., Hashimoto, K., Koike, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.072 · Cited by 137
Moszczyńska, A., & Callan, S. P. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.238501 · Cited by 136
Thomas, D. M., & Kuhn, D. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.049 · Cited by 132
Cunha‐Oliveira, T., Rego, A. C., Cardoso, S. M., Borges, F., Swerdlow, R. H., Macedo, T., & Oliveira, C. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.061 · Cited by 129
Rose, M. E., & Grant, J. E. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802177656 · Cited by 121
Mandyam, C. D., Wee, S., Crawford, E. F., Eisch, A. J., Richardson, H. N., & Koob, G. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.010 · Cited by 125
Zhu, J. P. Q., Xu, W., & Angulo, J. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.055 · Cited by 119
Emerging research on methamphetamine
Maxwell, J. C. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165592.52811.84 · Cited by 116
A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection
Kraft-Terry, S. D., Buch, S. J., Fox, H. S., & Gendelman, H. E. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.042 · Cited by 115
Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension
Chen, P.-I., Cao, A., Miyagawa, K., Tojais, N. F., Hennigs, J. K., Li, C. G., Sweeney, N. M., Inglis, A. S., Wang, L., Li, D., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90427 · Cited by 106
Muneer, P. M. A., Alikunju, S., Szlachetka, A. M., Murrin, L. C., & Haorah, J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-23 · Cited by 104
Simões, A. P., Silva, A. P., Pereira, F. C., Marques, E., Grade, S., Milhazes, N., Borges, F., Ribeiro, C., & Macedo, T. R. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.044 · Cited by 104
Marcondes, M. C. G., Flynn, C. T., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090953 · Cited by 98
Beauvais, G., Atwell, K., Jayanthi, S., Ladenheim, B., & Cadet, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028946 · Cited by 98
Self-citationWong, A. W., McCallum, G. P., Jeng, W., & Wells, P. G. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2557-08.2008 · Cited by 96
Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity
Miyazaki, I., Asanuma, M., Kikkawa, Y., Takeshima, M., Murakami, S., Miyoshi, K., Sogawa, N., & Kita, T. (2010) · Glia · doi:10.1002/glia.21112 · Cited by 96
Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02906.x · Cited by 94
Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum
Thiriet, N., Deng, X., Solinas, M., Ladenheim, B., Curtis, W., Goldberg, S. R., Palmiter, R. D., & Cadet, J. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4893-04.2005 · Cited by 91
Self-citationMethamphetamine-induced neurotoxicity: the road to Parkinson’s disease
Thrash, B., Kariharan, T., Ahuja, M., Suppiramaniam, V. D., & Dhanasekaran, M. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70158-6 · Cited by 88
Du, S., Qiao, D., Chen, C., Chen, S., Liu, C., Lin, Z., Wang, H., & Xie, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00409 · Cited by 82
Kongsuphol, P., Mukda, S., Nopparat, C., Villarroel, A., & Govitrapong, P. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00648.x · Cited by 81
Melega, W. P., Jorgensen, M. J., Laćan, G., Way, B. M., Pham, J., Morton, G. G., Cho, A. K., & Fairbanks, L. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301502 · Cited by 78
Genetically correlated effects of selective breeding for high and low methamphetamine consumption
Wheeler, J. M., Reed, C. L., Burkhart‐Kasch, S., Li, N., Cunningham, C. L., Janowsky, A. J., Franken, F. H., Wiren, K. M., Hashimoto, J. G., Scibelli, A. C., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00522.x · Cited by 77
Kanthasamy, A., ANANTHARAM, V., ALI, S. F., & KANTHASAMY, A. G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.022 · Cited by 75
Krasnova, I. N., Ladenheim, B., & Cadet, J. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2881fje · Cited by 74
Self-citationPharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine
Haile, C. N., Kosten, T. R., & Kosten, T. A. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990902825447 · Cited by 76
Protein expression profile in the striatum of acute methamphetamine-treated rats
Iwazaki, T., McGregor, I. S., & Matsumoto, I. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.052 · Cited by 74
Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity
Miyazaki, I., & Asanuma, M. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9843-1 · Cited by 71
Shin, E., Duong, C. X., Nguyen, X.-K. T., Li, Z., Bing, G., Bach, J. H., Park, D. H., Nakayama, K. I., Ali, S. F., Kanthasamy, A. G., et al. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.001 · Cited by 71
Self-citationShafahi, M., Vaezi, G., Shajiee, H., Sharafi, S., & Khaksari, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2644-2 · Cited by 70
Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse Olfactory Bulb
Deng, X., Ladenheim, B., Jayanthi, S., & Cadet, J. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.010 · Cited by 70
Self-citationNeuropsychological deficits in adolescent methamphetamine abusers
King, G., Alicata, D., Cloak, C. C., & Chang, L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1949-x · Cited by 70
Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., Shimizu, E., & Iyo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300512 · Cited by 70
Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs
Itzhak, Y., & Ali, S. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.004 · Cited by 67
Shepard, J. D., Chuang, D., Shaham, Y., & Morales, M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0316-4 · Cited by 66
Huang, J., Zheng, Y., Gao, D., Hu, M., & Yuan, T. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00999 · Cited by 65
Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., & Iyo, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.019 · Cited by 65
Anantharam, V., Lehrmann, E., Kanthasamy, A., Yang, Y., Banerjee, P., Becker, K. G., Freed, W. J., & Kanthasamy, A. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.02.003 · Cited by 65
Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion
Gillingwater, T. H. (2006) · Brain · doi:10.1093/brain/awl101 · Cited by 67
Attenuation of Cocaine and Methamphetamine Neurotoxicity by Coenzyme Q10
Klongpanichapak, S., Govitrapong, P., SHARMA, S. K., & Ebadi, M. (2006) · Neurochemical Research · doi:10.1007/s11064-005-9025-3 · Cited by 65
Cai, D., Huang, E., Luo, B., Yang, Y., ZHANG, F., Liu, C., Lin, Z., Xie, W.-B., & Wang, H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.67 · Cited by 62
Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., Huber, J. D., & Matsumoto, R. R. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.009 · Cited by 60
The Scourge of Methamphetamine: Impact on a Level I Trauma Center
Swanson, S. M., Sise, C. B., Sise, M. J., Sack, D. I., Holbrook, T. L., & Paci, G. M. (2007) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318074d3ac · Cited by 61
Alteration of blood-brain barrier function by methamphetamine and cocaine
Dietrich, J. B. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0777-y · Cited by 61
Thomas, D. M., Angoa‐Pérez, M., Francescutti, D. M., Shah, M. M., & Kuhn, D. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06950.x · Cited by 59
Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation
Cadet, J. L., & Krasnova, I. N. (2007) · Neurotoxicity Research · doi:10.1007/bf03033915 · Cited by 59
Self-citationNeurotoxicology of Synthetic Cathinone Analogs
Angoa‐Pérez, M., Anneken, J. H., & Kuhn, D. M. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_21 · Cited by 60
Neurotoxic Effects of Methamphetamine
Thrash, B., Karuppagounder, S. S., Uthayathas, S., Suppiramaniam, V. D., & Dhanasekaran, M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0042-5 · Cited by 59
Persistence of tolerance to methamphetamine-induced monoamine deficits
Danaceau, J. P., Deering‐Rice, C. E., Day, J. E., Smeal, S. J., Johnson‐Davis, K. L., Fleckenstein, A. E., & Wilkins, D. G. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.045 · Cited by 59
Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men'
Itzhak, Y., & Achat‐Mendes, C. (2004) · IUBMB Life · doi:10.1080/15216540410001727699 · Cited by 59
Kitamura, O., Tokunaga, I., Gotohda, T., & Kubo, S. (2006) · International Journal of Legal Medicine · doi:10.1007/s00414-006-0087-9 · Cited by 59
Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway
Sharikova, A. V., Quaye, E., Park, J. Y., Maloney, M. C., Desta, H., Thiyagarajan, R., Seldeen, K. L., Parikh, N. U., Sandhu, P., Khmaladze, A. T., et al. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9787-4 · Cited by 59
Cheng, W. S., Garfein, R. S., Semple, S. J., Strathdee, S. A., Zians, J. K., & Patterson, T. L. (2009) · Substance Use & Misuse · doi:10.3109/10826080902869620 · Cited by 58
He, C., He, Q., Deng, C., Shi, L., Zhu, D., Fu, Y., Cao, H., & Cheng, J. (2010) · Chemical Communications · doi:10.1039/c0cc01972k · Cited by 58
Graham, D. L., Noailles, P.-A. H., & Cadet, J. L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05269.x · Cited by 58
Self-citationCadet, J. L., McCoy, M. T., Cai, N. S., Krasnova, I. N., Ladenheim, B., Beauvais, G., Wilson, N., Wood, W. H., Becker, K. G., & Hodges, A. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007812 · Cited by 58
Self-citationCyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080242 · Cited by 58
Li, X., Wang, H., Qiu, P., & Luo, H. L. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.014 · Cited by 57
Golsorkhdan, S. A., Boroujeni, M. E., Aliaghaei, A., Abdollahifar, M., Ramezanpour, A., Nejatbakhsh, R., Anarkooli, I. J., Barfi, E., & Fridoni, M. J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112300 · Cited by 55
He, J., Xu, H., Yang, Y., Zhang, X., & Li, X. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.060 · Cited by 54
Clemens, K. J., McGregor, I. S., Hunt, G. E., & Cornish, J. L. (2007) · Drug and Alcohol Review · doi:10.1080/09595230601036945 · Cited by 55
Huang, Y.-N., Yang, L.-Y., Wang, J.-Y., Lai, C.-C., Chiu, C.-T., & Wang, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9561-z · Cited by 57
Kaewsuk, S., Sae‐ung, K., Phansuwan‐Pujito, P., & Govitrapong, P. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.010 · Cited by 53
Caligiuri, M. P., & Buitenhuys, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300859 · Cited by 52
Methamphetamine and its impact on dental care.
Klasser, G. D., & Epstein, J. B. (2005) · PubMed · Cited by 52
Caspase-11 Plays an Essential Role in Methamphetamine-Induced Dopaminergic Neuron Apoptosis
Huang, W., Xie, W., Qiao, D., Qiu, P., Huang, E., Li, B., Chen, C., Liu, C., Wang, Q., Lin, Z., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv014 · Cited by 51
Sokolov, B. P., & Cadet, J. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300891 · Cited by 51
Self-citationThe Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation
Shi, S., Chen, T., & Zhao, M. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03513-9 · Cited by 53
Madden, L. J., Flynn, C. T., Zandonatti, M. A., May, M., Parsons, L. H., Katner, S. N., Henriksen, S. J., & Fox, H. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300575 · Cited by 50
Valvassori, S. S., Petronilho, F. C., Réus, G. Z., Steckert, A. V., Oliveira, V. B. M., Boeck, C. R., Kapczinski, F. P., Dal‐Pizzol, F., & Quevedo, J. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.02.012 · Cited by 49
Psychiatric Symptoms and HPA Axis Function in Adolescent Methamphetamine Users
King, G., Alicata, D., Cloak, C. C., & Chang, L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9206-y · Cited by 49
Chen, H., Wu, J., Zhang, J., Fujita, Y., Ishima, T., Iyo, M., & Hashimoto, K. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2619-3 · Cited by 49
Scheidweiler, K. B., & Huestis, M. A. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.03.020 · Cited by 48
Serotonin neurotoxins — past and present
Baumgarten, H. G., & Lachenmayer, L. (2004) · Neurotoxicity Research · doi:10.1007/bf03033455 · Cited by 49
Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
Kaushal, N., & Matsumoto, R. R. (2011) · Current Neuropharmacology · doi:10.2174/157015911795016930 · Cited by 48
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 47
Environmental Enrichment does not Reduce the Rewarding and Neurotoxic Effects of Methamphetamine
Thiriet, N., Gennequin, B., Lardeux, V., Chauvet, C., Decressac, M., Janet, T., Jaber, M., & Solinas, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9158-2 · Cited by 51
Methamphetamine induces macropinocytosis in differentiated SH-SY5Y human neuroblastoma cells
Nara, A., Aki, T., Funakoshi, T., & Uemura, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.043 · Cited by 46
Metadata
- Authors
- Cadet, J. L., Jayanthi, S., & Deng, X.
- Affiliations
- National Institutes of Health (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 17
- Issue
- 13
- Pages
- 1775-1788
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2083351059
- Cited by
- 286
- References
- 212
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 10 · 2012: 14
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute on Drug Abuse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, neurotoxicity, neuronal apoptosis, nerve terminal degeneration, monoaminergic systems, reactive oxygen species, transcription factors, cell death genes, endoplasmic reticulum stress, mitochondrial dysfunction, caspase activation
- MeSH terms
- Animals, Humans, Methamphetamine, Models, Biological, Nerve Degeneration, Neurons, Signal Transduction, Apoptosis, Presynaptic Terminals, Cytoprotection, Neurotoxicity Syndromes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review